Menu

Our latest news

March 29th, 2018

10 Key Takeaways from eyeforpharma Barcelona from our Chief Executive, Kay Wesley

What changes are afoot in the pharma industry? How do patients and doctors feel about pharma? How will big data transform healthcare?

Three of the Kanga team attended eyeforpharma this year. We met patient experts and doctors who gave us their views. We saw great presentations on pioneering programs and the ‘insider view’ on pharma’s transformation, as well as refreshing perspectives from other industries. We had insightful conversations at the Kanga stand and were inspired by many of our co-finalists at the awards presentations. Check out our 10 key takeaways from Kay’s latest blog post.

 

March 13th, 2018

LivingwithNETs wins ‘Most Valuable Patient Initiative’ at eyeforpharma awards!

One of Kanga's projects has won an award at the annual eyeforpharma conference in Barcelona!

LivingwithNETs.com  is a website developed with Ipsen in collaboration with patients and healthcare professionals. It won the ‘Most Valuable Patient Initiative’ – an award that recognises projects that demonstrate real understanding for the patient requirements prior to implementation and have a significant positive impact on the patient’s life.

Collecting the award, Ipsen Chief Patient Affairs Officer Isabelle Bocher-Pianka, said: “This project was important because we wanted to change the lives of patients suffering from neuroendocrine tumours…firstly it helps to identify the early symptoms, but, more importantly, it is a full guide to living with the disease. We worked extensively with the patients and we followed their journey from pre-diagnosis all the way to life with NETS.”

The project was a finalist along with several other strong patient initatives in the annual eyeforpharma Europe awards.

Keep following our Twitter account for more news on awards.

March 1st, 2018

Feel+ Shortlisted for award

Feel+, the prostate cancer wellness program, is a finalist for an award at eyeforpharma Europe 2018

The Feel+ Program has been shortlisted as a finalist for an award at the upcoming European eyeforpharma 2018 conference (March 13-15 2018), held in Barcelona.

Ferring’s Feel+ Prostate Cancer Wellness program, developed in conjunction with Cliniques Universitaires Saint-Luc, and created in its digital form by Kanga, has been shortlisted for ‘Most Valuable Collaboration’. The award looks for projects that provide real, tangible differences to the lives of their patients both in the short and long term.

More information on the awards and finalists.

March 1st, 2018

LivingwithNETs shortlisted for award

LivingwithNETs, for NETs patients, is a finalist in the European eyeforpharma 2018 awards

LivingWithNETs.com – designed and built by Kanga for Ipsen, has been shortlisted as a finalist for a European award at the annual eyeforpharma 2018 conference. The project is a finalist in ‘Most Valuable Patient Initiative’ category.

The conference takes place between the 13th and 15th of March – here you can see more information about the awards and finalists

November 1st, 2017

Acromunity.com Launched

Information and support for people with Acromegaly.

Acromunity is an online resource that Kanga supported Ipsen Pharma to design and develop. It provides information and support for people with acromegaly, their family and friends, and others who are interested learning more about the condition. The content was conceived, developed and fine-tuned with input from patients living with acromegaly and healthcare professionals.

September 27th, 2017

Appointments: James Fallon, Production Executive

James joins us today as Production Executive

James is a Digital Producer responsible for creating and editing videos, building email newsletters, managing client web content and assisting with the production of training materials and delivery of training sessions.

James’ digital marketing experience started following the completion of his degree in Journalism & Media studies. He worked in the Middle East as a journalist and producer of both print and digital content for a range of magazines and websites prior to returning the UK and working for a number of companies managing their digital marketing.

 

August 2nd, 2017

LivingwithNETs Brazil Launched

New website for patients in Brazil with neuroendocrine tumours.

Kanga has supported Ipsen Pharmaceuticals to launch VivendoCom, the localised Brazilian version of the global Living with NETs, the support resource for patients with neuroendocrine tumours.

Developed with patients and healthcare professionals this service addresses the needs of patients throughout their journey, from early symptoms through to diagnosis and living with the condition. Many patients with NETs live successful lives on treatment, and LivingwithNETs aims to support them in this.

July 28th, 2017

Digital Experimental Cancer Team Website Launch

Kanga has partnered with The Christie Hospital's Digital Experimental Cancer Team to launch its new website.

The Digital Experimental Cancer Medicine Team was created to link clinical science with academic and scientific research with strategic Digital ECMT Logopartners, to transform the way that decisions in cancer treatments are made.  The website, DigitalECMT.org, explains this innovative approach to to all potential partners and stakeholders – doctors, nurses, researchers, patients and sponsors.

July 28th, 2017

LivingwithNETs Germany Launched

New website for patients in Germany with neuroendocrine tumours.

Mein Lieben Mit NETKanga has supported Ipsen Pharmaceuticals to launch Mein Lieben Mit NET, the localised German version of the global Living with NETs, the support resource for patients with neuroendocrine tumours.

Developed with patients and healthcare professionals this service addresses the needs of patients throughout their journey, from early symptoms through to diagnosis and living with the condition. Many patients with NETs live successful lives on treatment, and LivingwithNETs aims to support them in this.

Sign up to our newsletter

Enter your email address below to receive notifications of new services or blog posts by (occasional) email.